EPS-I polysaccharide protects Mycoplasma pulmonis from phagocytosis

FEMS Microbiology Letters

Volumn 338, Issue 2, 2013, Pages 155-160

  Shaw, Brandon M ^a,b   Daubenspeck, James M ^a   Simmons, Warren L ^a   Dybvig, Kevin ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Capsule; Innate immunity; MH S cells; Yeast extract

Indexed keywords

BACTERIAL POLYSACCHARIDE;

ANIMAL CELL; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM MUTANT; HOST PATHOGEN INTERACTION; LUNG ALVEOLUS MACROPHAGE; MOUSE; MYCOPLASMA PULMONIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED BALB C; MYCOPLASMA PULMONIS; PHAGOCYTOSIS; POLYSACCHARIDES, BACTERIAL;

MUS; MYCOPLASMA PULMONIS; MYCOPLASMATALES;

EID: 84871718360     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/1574-6968.12048     Document Type: Article

References (33)

1. Almeida RA & Rosenbusch RF (1991) Capsulelike surface material of Mycoplasma dispar induced by in vitro growth in culture with bovine cells is antigenically related to similar structures expressed in vivo. Infect Immun 59: 3119-3125.
2. Almeida RA, Wannemuehler MJ & Rosenbusch RF (1992) Interaction of Mycoplasma dispar with bovine alveolar macrophages. Infect Immun 60: 2914-2919.
3. Bolland JR & Dybvig K (2012) Mycoplasma pulmonis Vsa proteins and polysaccharide modulate adherence to pulmonary epithelial cells. FEMS Microbiol Lett 331: 25-30.
4. Bolland JR, Simmons WL, Daubenspeck JM & Dybvig K (2012) Mycoplasma polysaccharide protects against complement. Microbiology 158: 1867-1873.
5. Brooks BW, Lutze-Wallace CL, Lu P & Robertson RH (2004) Identification and serological specificity of a polysaccharide component from Mycoplasma bovis. Vet Res Commun 28: 197-208.
6. Chambaud I, Heilig R, Ferris S et al. (2001) The complete genome sequence of the murine respiratory pathogen Mycoplasma pulmonis. Nucleic Acids Res 29: 2145-2153.
7. Daubenspeck JM, Bolland JR, Luo W, Simmons WL & Dybvig K (2009) Identification of exopolysaccharide-deficient mutants of Mycoplasma pulmonis. Mol Microbiol 72: 1235-1245.
8. 2 is associated with damaged alveolar macrophages. Am Rev Respir Dis 145: 406-411.
9. Denison AM, Clapper B & Dybvig K (2005) Avoidance of the host immune system through phase variation in Mycoplasma pulmonis. Infect Immun 73: 2033-2039.
10. Finlay BB & Falkow S (1989) Common themes in microbial pathogenicity. Microbiol Rev 53: 210-230.
11. Hickman-Davis J, Michalek SM, Gibbs-Erwin J & Lindsey JR (1997) Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-sensitive C3H mice. Infect Immun 65: 2278-2282.
12. Kraft M, Adler KB, Ingram JL, Crews AL, Atkinson TP, Cairns CB, Krause DC & Chu HW (2008) Mycoplasma pneumoniae induces airway epithelial cell expression of MUC5AC in asthma. Eur Respir J 31: 43-46.
13. Li Y, Youngren B, Sergueev K & Austin S (2003) Segregation of the Escherichia coli chromosome terminus. Mol Microbiol 50: 825-834.
14. Manna D, Breier AM & Higgins NP (2004) Microarray analysis of transposition targets in Escherichia coli: the impact of transcription. Proc Natl Acad Sci USA 101: 9780-9785.
15. Mbawuike IN & Herscowitz HB (1989) MH-S, a murine alveolar macrophage cell line: morphological, cytochemical, and functional characteristics. J Leukoc Biol 46: 119-127.
16. Neyrolles O, Brenner C, Prevost MC, Fontaine T, Montagnier L & Blanchard A (1998) Identification of two glycosylated components of Mycoplasma penetrans: a surface-exposed capsular polysaccharide and a glycolipid fraction. Microbiology 144: 1247-1255.
17. Perez-Vilar J, Randell SH & Boucher RC (2004) C-Mannosylation of MUC5AC and MUC5B Cys subdomains. Glycobiology 14: 325-337.
18. Razin S, Yogev D & Naot Y (1998) Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev 62: 1094-1156.
19. Sankaran K & Herscowitz HB (1995) Phenotypic and functional heterogeneity of the murine alveolar macrophage-derived cell line MH-S. J Leukoc Biol 57: 562-568.
20. Shaw BM, Simmons WL & Dybvig K (2012) The Vsa shield of Mycoplasma pulmonis is antiphagocytic. Infect Immun 80: 704-709.
21. Shen X, Yu H, Gumulak J, French CT, Zou N & Dybvig K (2000) Gene rearrangements in the vsa locus of Mycoplasma pulmonis. J Bacteriol 182: 2900-2908.
22. Simmons WL & Dybvig K (2003) The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement killing, hemadsorption, and adherence to polystyrene. Infect Immun 71: 5733-5738.
23. Simmons WL & Dybvig K (2007) Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidin. Infect Immun 75: 3696-3699.
24. Simmons WL, Denison AM & Dybvig K (2004) Resistance of Mycoplasma pulmonis to complement lysis is dependent on the number of Vsa tandem repeats: shield hypothesis. Infect Immun 72: 6846-6851.
25. Tajima M & Yagihashi T (1982) Interaction of Mycoplasma hyopneumoniae with the porcine respiratory epithelium as observed by electron microscopy. Infect Immun 37: 1162-1169.
26. Tajima M, Yagihashi T & Miki Y (1982) Capsular material of Mycoplasma gallisepticum and its possible relevance to the pathogenic process. Infect Immun 36: 830-833.
27. Taylor-Robinson D, Furr PM, Davies HA, Manchee RJ, Mouches C & Bove JM (1981) Mycoplasmal adherence with particular reference to the pathogenicity of Mycoplasma pulmonis. Isr J Med Sci 17: 599-603.
28. Todd RF III (1996) The continuing saga of complement receptor type 3 (CR3). J Clin Invest 98: 1-2.
29. Underhill DM & Ozinsky A (2002) Phagocytosis of microbes: complexity in action. Annu Rev Immunol 20: 825-852.
30. van den Broek PJ (1989) Antimicrobial drugs, microorganisms, and phagocytes. Rev Infect Dis 11: 213-245.
31. Voynow JA (2002) What does mucin have to do with lung disease? Paediatr Respir Rev 3: 98-103.
32. Voynow JA & Rubin BK (2009) Mucins, mucus, and sputum. Chest 135: 505-512.
33. Westberg J, Persson A, Holmberg A, Goesmann A, Lundeberg J, Johansson KE, Pettersson B & Uhlen M (2004) The genome sequence of Mycoplasma mycoides subsp. mycoides SC type strain PG1T, the causative agent of contagious bovine pleuropneumonia (CBPP). Genome Res 14: 221-227.